[HTML][HTML] Dopamine signaling and myopia development: what are the key challenges

X Zhou, MT Pardue, PM Iuvone, J Qu - Progress in retinal and eye research, 2017 - Elsevier
In the face of an “epidemic” increase in myopia over the last decades and myopia
prevalence predicted to reach 2.5 billion people by the end of this decade, there is an urgent …

[HTML][HTML] Cellular and molecular specificity of pituitary gland physiology

C Perez-Castro, U Renner, MR Haedo… - Physiological …, 2012 - journals.physiology.org
The anterior pituitary gland has the ability to respond to complex signals derived from central
and peripheral systems. Perception of these signals and their integration are mediated by …

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients

L Vroonen, ML Jaffrain-Rea… - European journal of …, 2012 - academic.oup.com
Background Dopamine agonist resistance in prolactinoma is an infrequent phenomenon.
Doses of cabergoline (CAB) of up to 2.0 mg/week are usually effective in controlling …

Pituitary tumors contain a side population with tumor stem cell-associated characteristics

F Mertens, L Gremeaux, J Chen, Q Fu… - Endocrine-Related …, 2015 - erc.bioscientifica.com
Pituitary adenomas cause significant endocrine and mass-related morbidity. Little is known
about the mechanisms that underlie pituitary tumor pathogenesis. In the present study, we …

Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy

E Novella-Maestre, C Carda, A Ruiz-Sauri… - Biology of …, 2010 - academic.oup.com
Previous studies in an experimental mouse model of endometriosis have shown that the
dopamine agonist (DA) cabergoline (Cb2) reduces angiogenesis and endometriotic lesions …

Exploring stem cell biology in pituitary tumors and derived organoids

C Nys, YL Lee, H Roose, F Mertens… - Endocrine-Related …, 2022 - erc.bioscientifica.com
Pituitary tumorigenesis is highly prevalent and causes major endocrine disorders. Hardly
anything is known on the behavior of the local stem cells in this pathology. Here, we …

The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas

MV Recouvreux, MA Camilletti… - Journal of …, 2016 - joe.bioscientifica.com
Prolactinomas are the most frequently observed pituitary adenomas and most of them
respond well to conventional treatment with dopamine agonists (DAs). However, a subset of …

VEGF and CD31 association in pituitary adenomas

C Cristina, MI Perez-Millan, G Luque, RA Dulce… - Endocrine …, 2010 - Springer
Pituitary tumors are usually less vascularized than the normal pituitary, and the role of
angiogenesis in these adenomas is contentious. Appraisal of microvascular density and …

Angiogenesis in pituitary adenomas: human studies and new mutant mouse models

C Cristina, GM Luque, G Demarchi… - International journal …, 2014 - Wiley Online Library
The role of angiogenesis in pituitary tumor development has been questioned, as pituitary
tumors have been usually found to be less vascularized than the normal pituitary tissue …

Consider the context: Ras/ERK and PI3K/AKT/mTOR signaling outcomes are pituitary cell type-specific

AK Roof, A Gutierrez-Hartmann - Molecular and Cellular Endocrinology, 2018 - Elsevier
Conserved signaling pathways are critical regulators of pituitary homeostasis and, when
dysregulated, contribute to adenoma formation. Pituitary adenomas are typically benign and …